{"id":296234,"date":"2025-08-04T17:33:11","date_gmt":"2025-08-04T17:33:11","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/296234\/"},"modified":"2025-08-04T17:33:11","modified_gmt":"2025-08-04T17:33:11","slug":"prevention-ou-publicite-deguisee-la-campagne-contre-lobesite-du-laboratoire-novo-nordisk-denoncee-par-des-medecins","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/296234\/","title":{"rendered":"Pr\u00e9vention ou publicit\u00e9 d\u00e9guis\u00e9e ? La campagne contre l\u2019ob\u00e9sit\u00e9 du laboratoire Novo Nordisk d\u00e9nonc\u00e9e par des m\u00e9decins"},"content":{"rendered":"

D\u00c9CRYPTAGE – <\/strong>Des membres de la communaut\u00e9 m\u00e9dicale accusent le groupe pharmaceutique danois de promouvoir de fa\u00e7on d\u00e9tourn\u00e9e ses m\u00e9dicaments, comme le Wegovy, ce qui est ill\u00e9gal puisqu\u2019ils sont soumis \u00e0 prescription.<\/p>\n

Depuis un mois, de surprenantes affiches tr\u00f4nent dans plusieurs stations du m\u00e9tro parisien et des publications similaires d\u00e9ferlent sur les r\u00e9seaux sociaux. Une campagne de sensibilisation sign\u00e9e\u00a0Novo Nordisk<\/a>, laboratoire pharmaceutique danois qui vend deux des trois m\u00e9dicaments contre l\u2019ob\u00e9sit\u00e9<\/a>\u00a0commercialis\u00e9s en France, interpelle. Sur celles-ci, des personnes ob\u00e8ses posent, tout sourire, \u00e0 c\u00f4t\u00e9 de l\u2019inscription\u00a0: \u00abJ\u2019ai d\u00e9cid\u00e9 d\u2019agir pour moi et pour ma sant\u00e9\u00bb.<\/p>\n

Un lien dirige vers le site\u00a0de Novo Nordisk\u00a0Audel\u00e0dupoids.fr<\/a>, qui propose de calculer son\u00a0IMC<\/a>\u00a0et renvoie vers trois plateformes de prise de rendez-vous m\u00e9dicaux – Monpoidsmasant\u00e9.fr,\u00a0Doctolib<\/a>\u00a0et Livi – afin, en cas d\u2019ob\u00e9sit\u00e9 (lorsque l\u2019IMC est sup\u00e9rieur \u00e0 30), de \u00abparler de (son) poids avec (son) m\u00e9decin\u00bb. Il est pr\u00e9cis\u00e9 que les deux derniers sites sont des entit\u00e9s \u00abautonomes et ind\u00e9pendantes\u00bb et que le groupe danois n\u2019exerce \u00abaucune influence sur la fourniture de leurs services\u00bb. Mais le premier est une propri\u00e9t\u00e9 du laboratoire\u2026<\/p>\n

\n Cet article est r\u00e9serv\u00e9 aux abonn\u00e9s. Il vous reste 88% \u00e0 d\u00e9couvrir.\n <\/p>\n

\"Le<\/p>\n

Vous avez envie de lire la suite ?<\/p>\n

D\u00e9bloquez tous les articles imm\u00e9diatement.<\/p>\n

\n D\u00e9j\u00e0 abonn\u00e9\u00a0?
\n Connectez-vous
\n <\/a>\n <\/p>\n","protected":false},"excerpt":{"rendered":"D\u00c9CRYPTAGE – Des membres de la communaut\u00e9 m\u00e9dicale accusent le groupe pharmaceutique danois de promouvoir de fa\u00e7on d\u00e9tourn\u00e9e…\n","protected":false},"author":2,"featured_media":296235,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[442,228,440,441,436,1011,27,72,226,439,43651,233,626,229,71,435,437,227,438],"class_list":{"0":"post-296234","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-sante","8":"tag-administration-de-la-sante","9":"tag-diagnostic","10":"tag-droit-a-la-sante","11":"tag-education-sanitaire-education-sanitaire-individuelle-et-collective","12":"tag-environnement","13":"tag-fr","14":"tag-france","15":"tag-health","16":"tag-maladie","17":"tag-niveau-de-vie","18":"tag-novo-nordisk","19":"tag-obesite","20":"tag-paris","21":"tag-pathologie","22":"tag-sante","23":"tag-sante-de-la-population","24":"tag-services-medicaux","25":"tag-traitement","26":"tag-traitement-preventif"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/114971699178293556","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/296234","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=296234"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/296234\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/296235"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=296234"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=296234"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=296234"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}